Kerwin, Edward M <br/><br/>
Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).  [electronic resource] 

 -  COPD  Apr 2012 
 - 90-101 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1541-2563 
<br/><br/><label>Standard No.: </label>10.3109/15412555.2012.661492  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adult<br/>Aged<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Intention to Treat Analysis<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--administration & dosage<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Quality of Life<br/>Spirometry<br/>Surveys and Questionnaires<br/>Treatment Outcome<br/>Tropanes--administration & dosage